#Pharmaceutical Companies #Control The #Government
Pharmaceutical Companies have so much control in the USA and other
parts of the world that for every U.S. congressman their two
Pharmaceutical Company lobbyists in their pocket.
Pharmaceuticals companies Invested almost $2 billion in Campaign Contributions and Lobbying just last year.
Johnson & Johnson $653,988
GLAXOSMITHKLINE $609,654
Novartis AG $499,290
United Therapeautics $497,250
Novo Nordisk $496,688
Cardinal Health $434,290
Genentech Inc $428,685
Boston Scientific Corp $379,650
Pfizer Inc $1,534,390
Amgen Inc $1,333,514
McKesson Corp $1,110,900
Sanofi $939,180
AstraZeneca PLC $801,583
ABBOTT LABORATORIES $796,509
Ischemix $778,900
Merck & Co $927,859
DE Shaw Research $833,597
Eli Lilly & Co $764,575
AmerisourceBergen Corp $729,321
AbbVie Inc $688,950
GLAXOSMITHKLINE $609,654
Novartis AG $499,290
United Therapeautics $497,250
Novo Nordisk $496,688
Cardinal Health $434,290
Genentech Inc $428,685
Boston Scientific Corp $379,650
Pfizer Inc $1,534,390
Amgen Inc $1,333,514
McKesson Corp $1,110,900
Sanofi $939,180
AstraZeneca PLC $801,583
ABBOTT LABORATORIES $796,509
Ischemix $778,900
Merck & Co $927,859
DE Shaw Research $833,597
Eli Lilly & Co $764,575
AmerisourceBergen Corp $729,321
AbbVie Inc $688,950
